Michael Mason's Net Worth

Michael Mason's net worth is estimated to be at least $9,975,963.26 as of 10/02/2022. CoreStreet's estimation of Michael Mason's net worth is based on their sale of stock and current holding of stock.

Michael Mason is CFO at Karyopharm Therapeutics Inc. They have executed at least 8 trades of stock as per SEC Form 4 filings. Their most recent trade was for 601 units of KPTI stock on 06/03/2022. Their biggest sale was on 01/04/2018 when they sold 36,745 units of Alnylam Pharmaceuticals Inc stock for $4,835,274.55. They typically trade 1 times per year.

Total value of insider buys:
  • $0.00
Total value of insider sells:
  • $9,975,963.26
Most recent insider trade:
  • June 3, 2022

Michael Mason's Insider Trading History

Karyopharm Therapeutics IncTitleAmountPriceTypeTotal Value
June 3, 2022
CFO601$6.04Sell$3,630.04
Feb. 7, 2022
CFO3,947$9.86Sell$38,917.42
Alnylam Pharmaceuticals IncTitleAmountPriceTypeTotal Value
Jan. 4, 2018
VP36,745$131.59Sell$4,835,274.55
May 16, 2017
VP9,375$70.00Sell$656,250.00
Dec. 15, 2014
VP22,162$97.50Sell$2,160,795.00
July 12, 2013
VP14,200$50.00Sell$710,000.00
July 1, 2013
VP27,000$32.00Sell$864,000.00
June 17, 2013
VP23,625$29.93Sell$707,096.25